Popular search terms:
Search Results207 results found
CSL Behring provides protein-based and recombinant therapies for bleeding disorders, immune deficiencies, hereditary angioedema and Alpha 1 antitrypsin deficiency, among others.
CSL Behring provides protein-based therapies for bleeding disorders, critical care, pulmonary disease, and other rare illnesses.
CSL Behring supports Material Transfer (MT) of post-approval product in limited quantity via the Material Transfer Agreement (MTA).
The CSL Behring products listed are covered by one or more patents in the United States and/or other countries.
CSL Behring's only US manufacturing plant is located in Kankakee, Illinois and employs more than 1,400 people.
CSL Behring offers an array of therapeutic support programs. We are here to help. Learn more today.
CSL Behring's Support and Assistance Programs
For support with product orders: 800-683-1288 / firstname.lastname@example.org. Plasma donors should visit: cslplasma.com/contact-us.
Social Media Community Guidelines for CSL Behring Corporate Channels
U.S. authorities say millions of Pine-Sol cleaning products could contain bacteria dangerous to those with weakened immune systems.